Financial Performance - For the fiscal year ending December 31, 2024, the company reported revenue of approximately HKD 3,364 million, an increase of about 6.1% compared to HKD 3,172 million in 2023[22]. - The gross profit margin for the same period was approximately 53.5%, with gross profit amounting to HKD 1,798 million, reflecting a 5.8% increase from HKD 1,700 million in 2023[22]. - Adjusted EBITDA for the fiscal year was approximately HKD 741 million, marking a historical high and an increase of about 2.1% from HKD 694 million in 2023[22]. - The net profit for the fiscal year was approximately HKD 406 million, a 1.2% increase from HKD 402 million in 2023[22]. - The adjusted EBITDA for the year ended December 31, 2024, was approximately HKD 741,481,000, an increase of about HKD 47,582,000 or 6.9% compared to 2023[26]. - Core business profit for the year ended December 31, 2024, was approximately HKD 434,982,000, reflecting an increase of about HKD 33,377,000 or 8.3% from 2023[26]. - Basic earnings per share for the year ended December 31, 2024, were HKD 0.432, up approximately 1.9% from HKD 0.424 in 2023[26]. - The total revenue for the year ended December 31, 2024, was HKD 3,364,018,000, representing a 6.1% increase from HKD 3,172,048,000 in 2023[25]. - The company reported a significant increase in overall market strategy and management, with a focus on dental technology and related production techniques[122]. Market Expansion and Strategy - The company is actively pursuing strategic acquisitions, including the acquisition of Hexa Ceram Company Limited, Thailand's largest dental laboratory, to enhance its product offerings and market coverage[20]. - The company has invested in digital workflows and proprietary dental solutions, positioning itself at the forefront of the digital transformation in the dental industry[9]. - The company aims to evolve into a comprehensive dental ecosystem by 2025, providing full support to customers and enhancing its product offerings, particularly in clear aligners[59]. - The company plans to establish a new business unit in Vietnam to serve mid to large dental clinic chains in North America, enhancing operational flexibility amid tariff challenges[51]. - The company aims to leverage digitalization trends in the dental industry to capture market share and enhance customer experience through advanced digital solutions[50]. - The company has made several landmark acquisitions, including the recent acquisition of Thailand's largest dental laboratory, Hexa Ceram, to diversify its global distribution and sales network[59]. - The company plans to strengthen its global leadership position through strategic measures, including acquisitions and partnerships, to expand its product offerings and enhance its distribution network[59]. Regional Performance - The company experienced growth in various regions, with Europe showing a double-digit increase in revenue, driven by the digitalization trend in the dental industry[29]. - In Europe, revenue amounted to HKD 1,618,436,000 for the fiscal year ending December 31, 2024, representing a 16.1% growth from HKD 1,399,371,000 in 2023, accounting for 48.1% of total revenue[50]. - North America generated revenue of HKD 752,083,000, a slight decrease of HKD 1,532,000 from HKD 753,615,000 in 2023, contributing approximately 22.3% to total revenue[51]. - The Greater China market recorded revenue of approximately HKD 662,210,000 for the year ending December 31, 2024, a decrease of about HKD 51,382,000 compared to the previous year, representing approximately 19.7% of total group revenue, down from 22.5%[55]. - The Australian market generated revenue of approximately HKD 264,752,000 for the year ending December 31, 2024, an increase of about HKD 10,411,000, accounting for approximately 7.9% of total group revenue, slightly down from 8.0%[56]. - The company reported a 30.1% increase in revenue from other markets, totaling HKD 66,537,000 compared to HKD 51,129,000 in 2023[46]. Operational Efficiency and Investments - The company has expanded its production capacity with the full operation of its Dongguan Phase II and Vietnam facilities to meet growing demand[11]. - The company is committed to sustainable growth and responsible business practices, focusing on minimizing waste and carbon emissions through digital production technologies[13]. - The company is committed to investing in digitalization to improve operational efficiency and customer experience, positioning itself at the forefront of industry integration[58]. - Research and development costs for the year were approximately HKD 43,564,000, representing about 3.1% of the group’s revenue, an increase from 2.4% in 2023[83]. - Capital expenditures for the year ended December 31, 2024, amounted to approximately HKD 153,504,000, with investments in cutting-edge technology machinery totaling approximately HKD 59,207,000, up from HKD 32,862,000 in 2023[83]. Financial Management and Governance - The group’s debt ratio as of December 31, 2024, was approximately 14%, a decrease from 16% in 2023, indicating a stable financial condition[87]. - The group has significant goodwill and intangible assets, which account for a major portion of total assets, with key assumptions for impairment testing remaining stable[104]. - The group has a diversified customer base, reducing the concentration of credit risk, as it only engages with reputable third parties[109]. - The management team has over 30 years of experience in the dental industry, contributing to the company's strategic planning and operational management[125]. - The company is committed to maintaining high standards of corporate governance through its independent board members[130]. - The board of directors includes experienced professionals with extensive backgrounds in dental and corporate governance, ensuring effective oversight and strategic direction[142]. Shareholder Information and Dividends - The company proposed a final dividend of HKD 0.092 per share for the year ended December 31, 2024, up from HKD 0.090 in 2023, pending shareholder approval[26]. - The company reported a mid-term dividend of HKD 0.08 per share for the six months ending June 30, 2024, an increase from HKD 0.06 for the same period in 2023[150]. - As of December 31, 2024, the company's distributable reserves were approximately HKD 320.27 million, down from HKD 397.84 million in 2023[158]. - The company will hold its annual general meeting on May 29, 2025, with a cutoff for share transfer registration from May 26 to May 29, 2025[151]. Risks and Challenges - Geopolitical risks and trade disputes are noted as factors that could complicate the global economic outlook, affecting the group's operations and supply chain[103]. - The group faces various foreign exchange risks, particularly with currencies such as RMB, EUR, AUD, and USD, and actively monitors these risks to maintain them at acceptable levels[108]. - The budgeted sales growth rate for 2024 is projected to be between 0% to 10%, consistent with the previous year[104].

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期： 2025年4月23日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 03600 | 說明 股份回購 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行 ...

FF305 呈交日期： 2025年4月22日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 03600 | 說明 股份回購 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | 已發行股份（不包括庫存股份）變動 | 佔有關事件前的現有已發 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | | 已發行股份（不包括庫存股份）數 | 行股份（不包括庫存股 | 庫存股份數目 | | | | | | 目 | 份）數目百分比 (註3) | | | | | 於下列日期開始 ...

表格類別： 股票 狀態： 新提交 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 公司名稱： 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期： 2025年4月17日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 03600 | 說明 | 股份回購 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期： 2025年4月16日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | | 是 | | | 證券代號 (如上市) | 03600 | 說明 | 股份回購 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 佔有關事件前的現有已發 ...

Summary of Conference Call Records Company Overview - The company discussed is Modern Dental, a leader in the dental industry, particularly in the field of dental prosthetics, which are primarily customized products [1][3][4]. Key Points and Arguments Industry Position and Business Model - Modern Dental operates in a fast-paced dental industry, serving dental professionals such as dentists and dental clinics [1]. - The company has established a strong relationship with dental professionals, facilitating daily communication and service delivery [2]. - Modern Dental's competitive advantage lies in its ability to produce customized products at scale, making it a unique leader in the industry [3]. Digital Transformation - The dental industry is undergoing a significant transformation due to digitalization, which raises service standards and operational efficiency [4]. - Modern Dental is transitioning from a product-focused company to a comprehensive service provider, enhancing dentists' capabilities through digital solutions [4][10]. Financial Performance - The company reported a revenue growth of approximately 6% for the year 2024, reaching HKD 33.1 billion, with a gross margin of around 53.5% [7][22]. - Adjusted EBITDA for the year was HKD 7.4 billion, with a return on equity of 15.3% [8][22]. - Core business profits increased by about 8%, with basic earnings per share reaching HKD 4.32 [8]. Market Expansion and Acquisitions - The company has expanded its market presence in Southeast Asia, including a recent acquisition in Thailand, which is expected to contribute an additional 6-7% to revenue by 2025 [2][21][23]. - The acquisition of a leading Thai company was completed at a PE ratio of approximately 10x, indicating a strategic investment for future growth [23]. Regional Performance - Australia showed the highest growth at 16% in local currency, attributed to strong digital capabilities and market leadership [10][11]. - The Greater China region experienced a modest growth of 3%, while Hong Kong faced a significant decline of 19.7% due to price competition with mainland China [18][19]. Response to Economic Conditions - Modern Dental's business is relatively insulated from economic fluctuations, with stable demand for dental services regardless of broader economic conditions [5]. - The company has a robust cash conversion capability, with over HKD 800 million in cash reserves, allowing it to navigate various market conditions effectively [7][33]. Challenges and Strategic Responses - The company is addressing challenges posed by tariffs and trade tensions, particularly in North America, where 75% of sales come from locally produced services [13][14][38]. - Modern Dental has a flexible business model that allows it to adapt to changing market conditions and manage costs effectively [15][16]. Future Outlook - The company is optimistic about maintaining high single-digit revenue growth in the coming years, supported by ongoing digitalization and market expansion efforts [21][30]. - Modern Dental aims to enhance its cash generation and shareholder returns through share buybacks and strategic investments [33][34]. Additional Important Information - The digitalization trend in the dental industry is expected to increase penetration rates significantly, with projections of reaching 50-70% in the next few years [29][30]. - The company emphasizes the importance of its distribution and sales networks, which are critical assets in maintaining competitive advantages in the market [9][10]. This summary encapsulates the key insights from the conference call, highlighting Modern Dental's strategic positioning, financial performance, market dynamics, and future growth prospects.

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期： 2025年4月15日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 03600 | 說明 | 股份回購 | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 第 2 頁 共 10 頁 v 1.3.0 公司名稱： 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期： 2025年4月14日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 03600 | 說明 | 股份回購 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 第 1 頁 共 10 頁 v 1.3.0 FF305 | 1). | 購回股份擬註銷但尚未註銷 | | 100,000 | % | HKD | 3.9922 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2024年12月3日 | | | | | | 2). | 購回股份擬註銷但尚未註銷 | | 100,000 | % | HKD | 4.0025 | | | 變動日期 | 2024年12月4日 | | | | | | 3). | 購回股份擬註銷但尚未註銷 | | 100,000 | % | HKD | 4.0293 | | | 變動日期 | 2024年12月5日 | | | | | | 4). | 購回股份擬註銷但尚未註銷 | | 100,000 | % | HKD | 4.0159 | | | 變動日期 | 2024年12月6日 | | | | | | 5). | 購回股份擬註銷但尚未註銷 | | 1 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期： 2025年4月10日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 03600 | 說明 | 股份回購 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行 ...